You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men

Authors

  1. Correspondence to Basil Donovan
    Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia;bdonovan{at}kirby.unsw.edu.au
View Full Text

Citation

Donovan B, Grulich AE
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men
BMJ Evidence-Based Medicine 2011;16:157-158.

Publication history

  • First published May 10, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions